Orrery Pulse

FDA approves Telix Pharmaceuticals’ TLX250-CDx for kidney cancer imaging?

0% current
7D range
0-0%
Net move
+0.0pp
24h volume
$0
7 day implied probability chart
May 3050% decision lineJun 6

Shareable snapshot generated from public Polymarket CLOB history.

Open dashboard stateCreate alertView market